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Supplementary Figure 1 
 
Supplementary Figure 1. The migration of the exon 1 HTT protein becomes increasingly 
retarded with age in the R6/2(CAG)90 mice. 
Western blot analysis of soluble and aggregated exon 1 HTT protein in brain lysates from 
R6/2(CAG)90 mice at 4, 8, 16 and 24 weeks of age immunoprobed with (A) S830 or (B) 4C9 
antibodies. ATP5B was used as a loading control. Aggregated HTT was already prominent in 
the stacking gel for R6/2(CAG)90 mice at 4 weeks of age. The migration of soluble exon1 HTT 
became increasingly retarded with age, possibly reflecting somatic instability of the CAG 






Supplementary Figure 2 
Supplementary Figure 2.  Instability and expansion indices for the extent of somatic 
instability in the R6/2(CAG)90 and R6/2(CAG)200 mice. The mean, standard deviation and 
data points for the (A) instability and (B) expansion indices of each tissue are illustrated.  
4 
 




















Supplementary Figure 3. The R6/2 transcript was expressed at higher levels in R6/2(CAG)90 
as compared to R6/2(CAG)200 brain regions.  
(A) Comparative levels of the HTT exon 1 transgene mRNA as measured by qPCR in brain 
regions from R6/2(CAG)90 and R6/2(CAG)200 mice at 2 weeks of age. R6/2(CAG)90 levels were 
2.5 – 3 fold higher in R6/2(CAG)90 than in R6/2(CAG)200 brain regions. (B) Comparative levels 
of the HTT exon 1 transgene mRNA as measured by qPCR in the cortex of R6/2(CAG)90 and 
R6/2(CAG)200 mice at 2, 4, 8 and 14 weeks of age. R6/2(CAG)90 transcript levels remained 
approximately 2 fold higher in R6/2(CAG)90 than in R6/2(CAG)200 mice from 4 to 14 weeks of 
age. (C) The levels of endogenous Htt were comparable in the cortex of R6/2(CAG)90, 
R6/2(CAG)200 and their wild type littermates at 2, 8 and 14 weeks of age. (A, C) R6/2(CAG)90 
(n = 9), R6/2(CAG)200 (n = 7), wild type (CAG)90 (n = 7), wild type (CAG)200 (n = 8). (B) n = 8 / 
genotype. Statistical analysis was two-tailed Student’s t-test or two-way ANOVA with 
Bonferroni post hoc correction. The test statistic, degrees of freedom and p values for the 
ANOVA are provided in Supplementary Table 8.  ***p ≤ 0.001. 
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Supplementary Figure 4. Brain sections from R6/2(CAG)200 mice immunoprobed with 
MW8 and counterstained with thionin to show the location of nuclei.  
Sections from the cortex, the CA1 region of the hippocampus and dentate gyrus from 
R6/2(CAG)200 mice at 8 weeks of age immunoprobed with MW8 and counterstained with 
thionin. At this age, nuclear aggregation in the R6/2(CAG)200 mice appeared as an inclusion, 
whereas in the R6/2(CAG)90 mice, aggregated HTT appeared as a diffuse signal that filled the 
entire nucleus (Fig. 5) DG = dentate gyrus. n = 3 / R6/2 genotype and n = 1 / wild type 
control. Scale bar = 50 μm. 
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Supplementary Figure 5. Antigen retrieval with formic acid revealed the presence of 
aggregated HTT in brain sections from R6/2(CAG)90 and R6/2(CAG)200 mice.  
Sections from the (A) cortex, (B) striatum, (C) CA1 region of the hippocampus and (D) 
dentate gyrus of the hippocampus from R6/2(CAG)90 and R6/2(CAG)200 mice at 4 and 8 
weeks of age were immunoprobed with the 4H7H7 antibody that detects polyglutamine 
peptides. No signal was obtained (-FA). Pre-treatment with formic acid (+FA) exposed the 
polyglutamine epitopes within huntingtin aggregates, allowing detection with 4H7H7, and 
demonstrating that the diffuse staining pattern detected with the MW8 antibody in Figs. 5 
and 6 represented an aggregated form of HTT. The extent of cytoplasmic aggregation was 
greater in the R6/2(CAG)200 hippocampus at 8 weeks of age than the R6/2(CAG)90 
hippocampus, both (C) dorsal to the CA1 and (D) in the hilus (cleft of the dentate gyrus). FA 
= formic acid. DG = dentate gyrus. n = 3 / R6/2 genotype and n = 1 / wild type control. Scale 





Supplementary Figure 6. Huntingtin aggregation in R6/2(CAG)90 brains.  
The pattern of HTT aggregation in coronal sections from R6/2(CAG)90 brains immunoprobed 
with MW8 at (A) 4 and (B) 8 weeks of age. The three boxes below the main panels indicate 
the location of the images shown in Figs. 5 and 6A. n = 3 / R6/2 genotype and n = 1 / wild 




Supplementary Figure 7. Huntingtin aggregation in R6/2(CAG)200 brains.  
The pattern of HTT aggregation in coronal sections from R6/2(CAG)200 brains immunoprobed 
with MW8 at (A) 4 and (B) 8 weeks of age. The three boxes below the main panels indicate 
the location of the images shown in Figs. 5 and 6A. n = 3 / R6/2 genotype and n = 1 / wild 




Supplementary Figure 8. Wild Type controls for sections immunoprobed with MW8.  
Coronal sections from wild type controls for the R6/2(CAG)90 brains immunoprobed with 
MW8 at (A) 4 and (B) 8 weeks of age, shown in Supplementary Fig. 6. n = 3 / R6/2 genotype 






Supplementary Figure 9. Wild Type controls for sections immunoprobed with MW8.  
Coronal sections from wild type controls for the R6/2(CAG)200 brains immunoprobed with 
MW8 at (A) 4 and (B) 8 weeks of age, shown in Supplementary Fig. 7. n = 3 / R6/2 genotype 






































Supplementary Figure 10. Huntingtin aggregation in R6/2(CAG)90 and R6/2(CAG)200 brains.  
The pattern of HTT aggregation in coronal sections from R6/2(CAG)90 at (A) 16 and (B) 24 
weeks of age and (C) R6/2(CAG)200 at 14 weeks of age immunoprobed with MW8. The three 
boxes below the main panels indicate the location of the images shown in Fig. 6B. n = 3 / 







































Supplementary Figure 11. Wild Type controls for sections immunoprobed with MW8.  
Coronal sections from wild type controls for the R6/2(CAG)90 at (A) 16 and (B) 24 weeks of 
age and (C) R6/2(CAG)200 at 14 weeks immunoprobed with MW8 and shown in 
Supplementary Fig. 10. n = 3 / R6/2 genotype and n = 1 / wild type control. Scale bar = 1,000 






Supplementary Figure 12. Full-sized loading control blots.  
Full-sized loading control blots immunoprobed with ATP5B for the western blots presented 





Supplementary Table 1. Real-time quantitative PCR assays  
 
Gene Supplier Primer/Probe Sequence (5’ to 3’) or Catalogue number 
Atp5b Primer Design  HK-DD-mo-900 
Bdnf IV Eurofins Genomics Forward CTGCCTTGATGTTTACTTTGACAAG 
Reverse GCAACCGAAGTATGAAATAACCATAG 
Probe TTCCACCAGGTGAGAAGAGTGATGACCAT 
Canx Primer Design  HK-DD-mo-900 
Cnr1 Eurofins Genomics Forward CACAAGCACGCCAATAACACA 
Reverse ACAGTGCTCTTGATGCAGCTTTC 
Probe CAGCATGCACAGGGCCGC 
Darpp32 Eurofins Genomics Forward CCCGACAGGTGGAGATGATC 
Reverse GCTGCACAGCTTTCAGTGATG 
Probe CTGCCATGCTTTTCCGGGTCTCAG 
Drd2 Eurofins Genomics Forward ACACCACTCAAGGGCAACTGT 
Reverse GGCGGGCAGCATCCA 
Probe GGGTCAGGACATGAAACTCTGCACCG 
Eif4a2 Primer Design  HK-DD-mo-900 
Grm2 Thermo Fisher  Mm01235831_m1 
Hrh3 Thermo Fisher  Mm00446706_m1 
Htr1a Thermo Fisher  Mm00434106_s1 
HTT 
transgene 





Eurofins Genomics Forward CTCAGAAGTGCAGGCCTTACCT 
Reverse GATTCCTCCGGTCTTTTGCTT 
Probe TGAATCTTCTTCCATGCCTGACCCGA 
Igfbp5 Eurofins Genomics Forward AAGGATTCTACAAGAGAAAGCAGTGTAA 
Reverse ACTTGTCCACACACCAGCAGAT 
Probe TCCCGTGGCCGCAAACGTG 
Kcnk2 Eurofins Genomics Forward GACTACGTGGCAGGTGGATCA 
Reverse GCCAGCCCAACGAGGAT 
Probe AATATCTGGACTTCTACAAGCCTGTGGTGTG 
Nr4a2 Eurofins Genomics Forward ATTTCCTCGAAAACTCCAATAACTCT 
Reverse TGAGGCGAGGACCCATACTG 
Probe CTGAAGCCATGCCTTGTGTTCAGGC 
Pcp4 Eurofins Genomics Forward CTGAGCTGTTCTGTGGGACCTA 
Reverse CGCTCCGGCACTTTGTCT 
Probe CTGCGGAGTCAGGCCAACATGA 
Pde10a Primer Design Forward TTGGCAAGTGGAGCATATTTAAC 
Reverse CCTGGAAACCTTTGGAGAGAAA 
Probe Custom assay / not supplied 
Penk1 Eurofins Genomics Forward ATGCAGCTACCGCCTGGTT 
Reverse GCAGCTGTCCTTCACATTCCA 
Probe AGGCGACATCAATTTCCTGGCGTG 
Pgam2 Primer Design Forward GGGAGGAGCAGGTGAAGAT 
Reverse GATGGAGGTGTAGTAGTTGTGTT 
Probe Custom assay / not supplied 
Rpl13a Primer Design  HK-DD-mo-900 
Uchl1 Eurofins Genomics Forward GGTACCATCGGGTTGATCCA 
Reverse AACTGTTTCAGGACGGATCCA 
Probe AACCAAGACAAGCTGGAATTTGAGGA 




Supplementary Table 2. Summary of antibodies 
 
Name Immunogen Epitope Species Concentration Reference / Source 
S830 HTT exon1 (53Q)  Sheep  
polyclonal 





HTT N171 (65Q) PolyQ Mouse 
monoclonal 
IHC (1:3,000) (Landles et al., 
2010) 
Alex Osmand 















WB (1:500) (Wang et al., 2008) 
Millipore MAB5374 





(Ko et al., 2001) 
CHDI Foundation 




WB (0.5 μg/ml) Abcam, ab14730 




WB (1:40,000) Sigma, T9026 
Histone-H3 Human synthetic 
peptide 
 Rabbit  
polyclonal 
WB (1:50,000) Millipore, 07-690 
aa = amino acid; WB = western blot; IHC = immunohistochemistry 
*EM48 detects an epitope in the C-terminal region of human exon 1 HTT and requires the 
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Supplementary Table 3. One-way ANOVA for qPCR analysis (Fig. 2) 
 
Striatal transcripts 4 weeks 8 weeks 
Cnr1  F(3,24) = 10.260, p < 0.001 F(3,25) = 52.268, p < 0.001 
Darpp32 F(3,24) = 3.776, p = 0.024 F(3,25) = 65.682, p < 0.001 
Drd2 F(3,24) = 6.665, p = 0.002 F(3,25) = 57.767, p < 0.001 
Pde10a F(3,24) = 112.362), p < 0.001 F(3,25) = 147.738, p < 0.001 
Penk1 F(3,24) = 15.791), p < 0.001 F(3,25) = 128.157, p < 0.001 
Cortical transcripts  
BdnfIV F(3,26) = 3.236, p = 0.038 F(3,27) = 11.119, p < 0.001 
Pgam2 F(3,25, = 4.012, p = 0.018 F(3,26) = 27.034, p < 0.001 
Grm2 F(3,26) = 19.501, p < 0.001 F(3,25) = 9.842, p < 0.001 
Hrh3 F(3,26) = 23.748, p < 0.001 F(3,25) = 73.196, p < 0.001 
Hrt1a F(3,26) = 6.085, p = 0.003 F(3,23) = 55.956, p < 0.001 
Cerebellar transcripts  
Igfbp5 F(3,26) = 15.483, p < 0.001 F(3,25) = 49.670, p < 0.001 
KcnK2 F(3,27) = 14.233, p < 0.001 F(3,25) = 21.277, p < 0.001 
Nr4a2 F(3,26) = 2.210, p = 0.111 F(3,25) = 16.999, p < 0.001 
Pcp4 F(3,27) = 20.598, p < 0.001 F(3,24) = 95.043, p < 0.001 
Uchl1 F(3,27) = 1.552, p = 0.224 F(3,25) =  7.339, p = 0.001 
 
 
Supplementary Table 4. Two-way ANOVA for Seprion-ELISA analysis (Fig. 3A-H) 
 
 2, 4 and 8 weeks of age 8, 16 weeks and end stage 
Striatum 
Genotype F(1,30) = 27.055, p < 0.001 F(1,34) = 4.861, p = 0.034 
Age F(2,30) = 262.161, p < 0.001 F(2,34) = 29.862, p < 0.001 
Genotype x Age F(2,30) = 13.972, p < 0.001 F(1,34) = 6.974, p = 0.012 
Cortex 
Genotype F(1,30) = 47.185, p < 0.001 F(1,33) = 0.668, p < 0.420 
Age F(2,30) = 146.657, p < 0.001 F(2,33) = 36.133, p < 0.001 
Genotype x Age F(2,30) = 10.992, p < 0.001 F(1,33) = 6.546, p = 0.0015 
Hippocampus 
Genotype F(1,30) = 17.636, p < 0.001 F(1,34) = 3.203, p = 0.082 
Age F(2,30) = 93.781, p < 0.001 F(2,34) = 35.686, p < 0.001 
Genotype x Age F(2,30) = 5.161, p = 0.012 F(1,34) = 16.370, p < 0.001 
Cerebellum 
Genotype F(1,29) = 19.696, p < 0.001 F(1,34) = 4.250, p = 0.047 
Age F(2,29) = 127.696, p < 0.001 F(2,34) = 40.299, p < 0.001 




Supplementary Table 5. Statistical analyses for the CAG instability data 
 
One-way ANOVA for CAG repeat instability (Supplementary Fig. 2) 
 
Instability index 
R6/2(CAG)90 F(7,111) = 266.7, p < 0.001 
R6/2(CAG)200 F(7,110) = 176.5, p < 0.001 
Expansion index 
R6/2(CAG)90 F(7,111) = 351.8, p < 0.001 
R6/2(CAG)200 F(7,110) = 159.7, p < 0.001 
 
Two-way ANOVA for CAG repeat instability (Supplementary Fig. 2) 
 
Instability index 
Tissue F(7,221) = 356.48, p < 0.001 
Genotype F(7,221) = 541.5, p < 0.001 
Tissue x Genotype F(7,221) = 34.79, p < 0.001 
Expansion index 
Tissue F(7,221) = 340.22, p < 0.001 
Genotype F(7,221) = 408.16, p < 0.001 
Tissue x Genotype F(7,221) = 38.45, p < 0.001 
 
 















*equal variance not assumed 
 
 4 weeks of age 
4C9 t(10) = -6.762, p < 0.001 
MW8 t(10) = -6.087, p < 0.001 
 8 weeks of age 
4C9 t(9) = 4.771 p = 0.001* 
MW8 t(9) = 2.829, p = 0.020* 
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Supplementary Table 8. Statistical analyses for the huntingtin transcript analyses 
(Supplementary Fig. 3) 
 
Two-tailed Student’s t-test for HTT-exon1 transcript at 2 weeks of age (Supplementary Fig. 
3A) 
Striatum t(13) = 6.262, p < 0.001 
Cortex t(14) = 13.297, p < 0.001 
Cerebellum t(14) = 12.549, p < 0.001 
 
Two-tailed Student’s t-test for cortical HTT-exon1 transcript (Supplementary Fig. 3B) 
 
2 weeks of age  t(13) = 4.031, p = 0.001 
4 weeks of age   t(12) = 7.184, p < 0.001 
8 weeks of age  t(13) = 7.439, p < 0.001  
14 weeks of age t(11) = 14.610, p < 0.001 
 
One-way ANOVA for cortical endogenous Htt transcript (Supplementary Fig. 3C) 
 
2 weeks of age F(3,27) = 0.936, p = 0.437 
8 weeks of age F(3,26) = 0.936, p = 0.493 
14 weeks of age F(3,27) = 2.368, p = 0.093 
 
 
Genotype F(3,48) = 184, p < 0.001 
Age F(3,48) = 15.3, p < 0.001 
Genotype x Age F(9,48) = 13.6, p < 0.001 
